Stock Price Quote

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE487.00-4.6 (-0.94 %)
PREV CLOSE ( ) 491.60
OPEN PRICE ( ) 492.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1968
TODAY'S LOW / HIGH ( )482.90 495.75
52 WK LOW / HIGH ( )380 824.55
NSE486.25-4.85 (-0.99 %)
PREV CLOSE( ) 491.10
OPEN PRICE ( ) 494.85
BID PRICE (QTY) 486.25 (163)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 16589
TODAY'S LOW / HIGH( ) 481.40 499.75
52 WK LOW / HIGH ( )380.25 827.3
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Rama Mohan Rao - Managing Director
Registered Office

Address Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-30211600

Email ir@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
KFIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

16Jan Board Meeting Intimation for Consider
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board..
30Oct Board Meeting Intimation for Consider
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board..
03Sep Neuland Laboratories soars on receivin
Neuland Laboratories is currently trading at Rs. 475.00, up by 13.70 poi..
30Aug Neuland Laboratories receives EIR from
Neuland Laboratories has received Establishment Inspection Report (EIR)..
24Jun USFDA completes inspection at Neuland
The United States Food and Drug Administration (USFDA) has completed ins..

Financials

in Millions
QTR Sep 19 ANNUAL 19
Net Profit85.74161.43
Gross Profit 123.4 198.35
Operating Profit 254.04613.57
Net Sales 1862.186668.3

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  3033.65 (3.27%)
M.Cap ( in Cr)50408.08
Torrent Pharma (BSE)
peergroup  2006.60 (4.26%)
M.Cap ( in Cr)33953.42
Piramal Enterprises (BSE)
peergroup  1627.05 (5.18%)
M.Cap ( in Cr)36697.48
Procter&Gamble Healt (BSE)
peergroup  4307.35 (0.64%)
M.Cap ( in Cr)7149.93
TTK Healthcare (BSE)
peergroup  563.70 (4.93%)
M.Cap ( in Cr)796.53

Shareholding Pattern

PROMOTERS 35.86%
NON-INSTITUTION 30.42%
MUTUAL FUNDS/UTI 1.92%
FI/BANKS/INSURANCE 0.17%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
ICICI Pru Pharma He...0.80

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. was incorporated in the year 07-01-1984. Its today's share price is 487. Its current market capitalisation stands at Rs 624.82 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6668.3 Cr and Total Income of Rs.6703.22 Cr. The company's management includes Sarada Bhamidipati, Christopher M Cimarusti, Homi Rustam Khusrokhan, Nirmala Murthy, Bharati Rao, William Gordon Mitchell, Parampally Vasudeva Maiya, Humayun Dhanrajgir, Davuluri Saharsh Rao, Davuluri Sucheth Rao, Davuluri Rama Mohan Rao, Davuluri Rama Mohan Rao.

It is listed on the BSE with a BSE Code of 524558 , NSE with an NSE Symbol of NEULANDLAB and ISIN of INE794A01010. It's Registered office is at Sanali Info Park, 'a' Block,Ground Floor,8-2-120/113,Road No.2, Banjara HillsHyderabad-500034, Telangana. Their Registrars are ACC Ltd. It's auditors are KS Aiyar & Co, Walker Chandik & Co LLP, Walker Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X